Neutrophil-Integrated Syncytial CAR Macrophages Show Promise for Cancer Immunotherapy
Cancer immunotherapy has gained a hybrid new contender: a living cell engineered by fusing two immune-system specialists into one tumor-hunting ...
Cancer immunotherapy has gained a hybrid new contender: a living cell engineered by fusing two immune-system specialists into one tumor-hunting ...
T-cell engagers (TCEs) are rapidly becoming a powerful immunotherapy platform, showing meaningful clinical responses across multiple tumor types. Yet their ...
In the rapidly evolving field of cancer immunotherapy, adoptive cell therapy (ACT) and immune cell engagers (ICEs) are carving out ...
In a groundbreaking advancement that could redefine the future of cancer immunotherapy, researchers have engineered an innovative in vivo “charging ...
In the relentless pursuit of more effective cancer immunotherapies, scientists have long been challenged by the complexity of harnessing the ...
Chimeric Antigen Receptor (CAR) T cell therapies have heralded a new era in oncological treatment, yielding transformative outcomes particularly in ...
At the cutting edge of cancer treatment, scientists at the Fralin Biomedical Research Institute at Virginia Tech Carilion (VTC) alongside ...
Cancer immunotherapy has revolutionized the treatment landscape for several malignancies by mobilizing the adaptive immune system, particularly T cells, to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine